| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.2B | $2.2B | $2.1B | $2.0B | $1.8B | $1.7B | $1.6B | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.4B | $0.5B | $0.6B | $0.6B | $0.5B | $0.3B | $0.4B | — |
| EPS (Basic) | $3.79 | $4.49 | $4.71 | $5.49 | $4.62 | $2.20 | $3.07 | — |
| EPS (Diluted) | $3.78 | $4.49 | $4.71 | $5.48 | $4.61 | $2.19 | $3.07 | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.0B | $11.8B | $11.5B | $11.2B | $11.3B | $11.2B | $11.2B | — |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.0B | $0.0B | $0.0B | $0.1B | $0.0B | $0.0B | — |
| Total Liabilities | $6.1B | $5.7B | $5.2B | $5.0B | $5.1B | $5.1B | $4.9B | — |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $5.7B | $5.9B | $6.1B | $6.0B | $6.0B | $5.9B | $6.1B | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $1.1B | $1.1B | $1.1B | $0.9B | $0.8B | $0.8B | — |
| Investing Cash Flow | $-0.7B | $-0.8B | $-0.8B | $-0.4B | $-0.3B | $-0.5B | $-0.2B | — |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.4B | $-0.3B | $-0.4B | $-0.7B | $-0.5B | $-0.4B | $-0.5B | — |